O'Keefe Andrew, Clarke Ann, St Pierre Yvan, Mill Jennifer, Asai Yuka, Eisman Harley, La Vieille Sebastien, Alizadehfar Reza, Joseph Lawrence, Morris Judy, Gravel Jocelyn, Ben-Shoshan Moshe
Discipline of Pediatrics, Faculty of Medicine, Memorial University, St. John's, Newfoundland and Labrador, Canada.
Division of Rheumatology, Department of Medicine, University of Calgary, Calgary, Alberta, Canada.
J Pediatr. 2017 Jan;180:217-221. doi: 10.1016/j.jpeds.2016.09.028. Epub 2016 Oct 12.
To determine the recurrence rate of anaphylaxis in children medically attended in an emergency department (ED), we performed a prospective cohort study to evaluate prehospital and ED management of children with recurrent anaphylaxis and to assess factors associated with recurrent anaphylaxis.
As part of the Cross-Canada Anaphylaxis Registry, parents of children with anaphylaxis identified prospectively in 3 EDs and through an emergency medical response service were contacted annually after presentation and queried on subsequent reactions. Cox regression analysis determined factors associated with recurrence.
Among 292 children who were registered as having had medical attended anaphylaxis, 68.5% completed annual follow-up questionnaires. Forty-seven patients experienced 65 episodes of anaphylaxis during 369 patient-years of follow-up. Food was the trigger in 84.6% of cases, and epinephrine was used in 66.2%. In 50.8%, epinephrine was used outside the health care facility, and 81.7% were brought to a health care facility for treatment. Asthma, reaction triggered by food, and use of epinephrine during the index episode increased the odds of recurrent reaction. Patients whose initial reaction was triggered by peanut were less likely to have a recurrent reaction.
We report a yearly anaphylaxis recurrence rate of 17.6% in children. There is substantial underuse of epinephrine in cases of anaphylaxis. Educational programs that promote effective avoidance strategies and prompt use of epinephrine are required.
为确定在急诊科接受治疗的儿童过敏反应复发率,我们开展了一项前瞻性队列研究,以评估复发性过敏反应儿童的院前及急诊科管理情况,并评估与复发性过敏反应相关的因素。
作为加拿大全国过敏反应登记处的一部分,对在3个急诊科前瞻性确定的过敏反应儿童以及通过紧急医疗响应服务确定的儿童,在其就诊后每年联系其父母,并询问后续反应情况。采用Cox回归分析确定与复发相关的因素。
在登记有过接受治疗的过敏反应的292名儿童中,68.5%完成了年度随访问卷。在369人年的随访期间,47名患者经历了65次过敏反应发作。84.6%的病例诱因是食物,66.2%使用了肾上腺素。50.8%在医疗机构外使用肾上腺素,81.7%被送往医疗机构治疗。哮喘、食物引发的反应以及在首次发作期间使用肾上腺素会增加复发反应的几率。初始反应由花生引发的患者复发反应的可能性较小。
我们报告儿童过敏反应的年复发率为17.